Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy

Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy

Lu Zhou,1 Huiping Shi,2 Wenyu Shi,1 Li Yang,1 Yaping Zhang,1 Mengqi Xu,1 Xiufang Chen,1 Yanv Zhu,1 Hui Mu,1 Xiaochun Wan,3 Zhonghua Yang,3 Ying Zeng,3,* Hong Liu1,* 1Hematology Department, Affiliated Hospital of Nantong University, Nantong, People’s Republic of China; 2Cardiovascular Biolo...

Full description

Bibliographic Details
Main Authors: Zhou L, Shi H, Shi W, Yang L, Zhang Y, Xu M, Chen X, Zhu Y, Mu H, Wan X, Yang Z, Zeng Y, Liu H
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:OncoTargets and Therapy
Subjects:
anti-cd19 car-t
bp-cml
bcr-abl1
t315i
Online Access:https://www.dovepress.com/durable-molecular-remission-in-a-lymphoid-bp-cml-patient-harboring-t31-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/durable-molecular-remission-in-a-lymphoid-bp-cml-patient-harboring-t31-peer-reviewed-article-OTT

Similar Items